VivoSim Labs, Inc. Share-based Payment Arrangement, Noncash Expense
VivoSim Labs, Inc. (VIVS) reported Share-based Payment Arrangement, Noncash Expense of $2.55 million for the 6-month period ending 2018-09-30, per its 10-Q filed 2018-11-08.
Discontinued › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2018-11-08
- VivoSim Labs, Inc. share-based payment arrangement, noncash expense for the quarter ending 2018-09-30 was $1.27M, a 44.56% decline year-over-year.
- VivoSim Labs, Inc. share-based payment arrangement, noncash expense for the quarter ending 2018-06-30 was $1.28M, a 37.67% decline year-over-year.
- VivoSim Labs, Inc. share-based payment arrangement, noncash expense for the quarter ending 2018-03-31 was $1.30M, a 29.64% decline year-over-year.
- VivoSim Labs, Inc. share-based payment arrangement, noncash expense for the quarter ending 2017-12-31 was $1.25M, a 38.06% decline year-over-year.
- VivoSim Labs, Inc. share-based payment arrangement, noncash expense for fiscal 2018 was $6.90M, a 6.62% decline from fiscal 2017.
- VivoSim Labs, Inc. share-based payment arrangement, noncash expense for fiscal 2017 was $7.39M, a 13.60% decline from fiscal 2016.
- VivoSim Labs, Inc. share-based payment arrangement, noncash expense for fiscal 2016 was $8.56M, a 21.88% increase from fiscal 2015.
- VivoSim Labs, Inc. share-based payment arrangement, noncash expense for fiscal 2015 was $7.02M, a 52.61% increase from fiscal 2014.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month | Share-based Payment Arrangement, Noncash Expense 59 month | Share-based Payment Arrangement, Noncash Expense 62 month | Share-based Payment Arrangement, Noncash Expense 65 month | Share-based Payment Arrangement, Noncash Expense 68 month | Share-based Payment Arrangement, Noncash Expense 71 month | Share-based Payment Arrangement, Noncash Expense 74 month | Share-based Payment Arrangement, Noncash Expense 77 month | Share-based Payment Arrangement, Noncash Expense 80 month | Share-based Payment Arrangement, Noncash Expense 83 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2018-09-30 | $1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-08 | $2.55M 10-Q · filed 2018-11-08 | $3.86M derived: sum of 3 quarters · filed 2018-11-08 | $5.11M derived: sum of 4 quarters · filed 2018-11-08 | ||||||||||
| 2018-06-30 | $1.28M 10-Q · filed 2018-08-09 | $2.58M derived: sum of 2 quarters · filed 2018-08-09 | $3.83M derived: sum of 3 quarters · filed 2018-08-09 | $6.13M derived: sum of 4 quarters · filed 2018-11-08 | ||||||||||
| 2018-03-31 | $1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-31 | $2.55M derived: sum of 2 quarters · filed 2018-05-31 | $4.85M derived: sum of 3 quarters · filed 2018-11-08 | $6.90M 10-K · filed 2018-05-31 | ||||||||||
| 2017-12-31 | $1.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-08 | $3.55M derived: sum of 2 quarters · filed 2018-11-08 | $5.60M 10-Q · filed 2018-02-08 | $7.45M derived: sum of 4 quarters · filed 2018-11-08 | ||||||||||
| 2017-09-30 | $2.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-11-08 | $4.35M 10-Q · filed 2018-11-08 | $6.20M derived: sum of 3 quarters · filed 2018-11-08 | $8.22M derived: sum of 4 quarters · filed 2018-11-08 | ||||||||||
| 2017-06-30 | $2.05M 10-Q · filed 2018-08-09 | $3.90M derived: sum of 2 quarters · filed 2018-08-09 | $5.92M derived: sum of 3 quarters · filed 2018-08-09 | $8.02M derived: sum of 4 quarters · filed 2018-08-09 | ||||||||||
| 2017-03-31 | $1.85M derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-31 | $3.87M derived: sum of 2 quarters · filed 2018-05-31 | $5.96M derived: sum of 3 quarters · filed 2018-05-31 | $7.39M 10-K · filed 2018-05-31 | ||||||||||
| 2016-12-31 | $2.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-02-08 | $4.11M derived: sum of 2 quarters · filed 2018-02-08 | $5.54M 10-Q · filed 2018-02-08 | $7.05M derived: sum of 4 quarters · filed 2018-05-31 | ||||||||||
| 2016-09-30 | $2.09M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-11-09 | $3.52M 10-Q · filed 2017-11-09 | $5.03M derived: sum of 3 quarters · filed 2018-05-31 | $8.13M derived: sum of 4 quarters · filed 2018-05-31 | ||||||||||
| 2016-06-30 | $1.43M 10-Q · filed 2017-08-09 | $2.94M derived: sum of 2 quarters · filed 2018-05-31 | $6.03M derived: sum of 3 quarters · filed 2018-05-31 | $8.21M derived: sum of 4 quarters · filed 2018-05-31 | ||||||||||
| 2016-03-31 | $1.51M derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-31 | $4.60M derived: sum of 2 quarters · filed 2018-05-31 | $6.78M derived: sum of 3 quarters · filed 2018-05-31 | $8.56M 10-K · filed 2018-05-31 | ||||||||||
| 2015-12-31 | $3.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-02-09 | $5.27M derived: sum of 2 quarters · filed 2017-02-09 | $7.05M 10-Q · filed 2017-02-09 | $8.85M derived: sum of 4 quarters · filed 2017-06-07 | ||||||||||
| 2015-09-30 | $2.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-11-03 | $3.95M 10-Q · filed 2016-11-03 | $5.76M derived: sum of 3 quarters · filed 2017-06-07 | $7.34M derived: sum of 4 quarters · filed 2017-06-07 | ||||||||||
| 2015-06-30 | $1.78M 10-Q · filed 2016-08-04 | $3.58M derived: sum of 2 quarters · filed 2017-06-07 | $5.17M derived: sum of 3 quarters · filed 2017-06-07 | $7.26M derived: sum of 4 quarters · filed 2017-06-07 | ||||||||||
| 2015-03-31 | $1.80M derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-07 | $3.39M derived: sum of 2 quarters · filed 2017-06-07 | $5.48M derived: sum of 3 quarters · filed 2017-06-07 | $7.02M 10-K · filed 2017-06-07 | ||||||||||
| 2014-12-31 | $1.58M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-02-08 | $3.68M derived: sum of 2 quarters · filed 2016-02-08 | $5.21M 10-Q · filed 2016-02-08 | $6.97M derived: sum of 4 quarters · filed 2016-06-09 | ||||||||||
| 2014-09-30 | $2.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-11-09 | $3.63M 10-Q · filed 2015-11-09 | $5.39M derived: sum of 3 quarters · filed 2016-06-09 | $6.15M derived: sum of 4 quarters · filed 2016-06-09 | ||||||||||
| 2014-06-30 | $1.54M 10-Q · filed 2015-08-10 | $3.30M derived: sum of 2 quarters · filed 2016-06-09 | $4.05M derived: sum of 3 quarters · filed 2016-06-09 | $5.33M derived: sum of 4 quarters · filed 2016-06-09 | ||||||||||
| 2014-03-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2016-06-09 | $2.51M derived: sum of 2 quarters · filed 2016-06-09 | $3.80M derived: sum of 3 quarters · filed 2016-06-09 | $4.60M 10-K · filed 2016-06-09 | $6.90M 10-K · filed 2014-06-10 | |||||||||
| 2013-12-31 | $752.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-02-06 | $2.04M derived: sum of 2 quarters · filed 2015-02-06 | $2.84M 10-Q · filed 2015-02-06 | $3.69M derived: sum of 4 quarters · filed 2015-06-09 | $5.14M 10-Q · filed 2014-02-06 | |||||||||
| 2013-09-30 | $1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-11-07 | $2.09M 10-Q · filed 2014-11-07 | $2.94M derived: sum of 3 quarters · filed 2015-06-09 | $3.09M derived: sum of 4 quarters · filed 2015-06-09 | $4.39M 10-Q · filed 2013-11-08 | |||||||||
| 2013-06-30 | $802.00K 10-Q · filed 2014-08-08 | $1.65M derived: sum of 2 quarters · filed 2015-06-09 | $1.80M derived: sum of 3 quarters · filed 2015-06-09 | $3.04M derived: sum of 4 quarters · filed 2015-06-09 | $3.10M 10-Q · filed 2013-08-09 | |||||||||
| 2013-03-31 | $848.00K 10-K · filed 2015-06-09 | $998.00K derived: sum of 2 quarters · filed 2015-06-09 | $2.24M derived: sum of 3 quarters · filed 2015-06-09 | $2.28M derived: sum of 4 quarters · filed 2015-06-09 | $2.30M 10-KT · filed 2013-05-24 | |||||||||
| 2012-12-31 | $150.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-02-06 | $1.39M derived: sum of 2 quarters · filed 2014-02-06 | $1.43M 10-Q · filed 2014-02-06 | $1.44M 10-K · filed 2015-06-09 | $1.45M 10-K · filed 2013-03-15 | |||||||||
| 2012-09-30 | $1.24M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-11-08 | $1.28M 10-Q · filed 2013-11-08 | $1.28M 10-Q · filed 2012-11-14 | $1.29M derived: sum of 4 quarters · filed 2015-06-09 | $1.30M 10-Q · filed 2012-11-14 | |||||||||
| 2012-06-30 | $39.00K 10-Q · filed 2013-08-09 | $42.64K 10-Q · filed 2012-08-14 | $49.40K derived: sum of 3 quarters · filed 2015-06-09 | $50.12K derived: sum of 4 quarters · filed 2015-06-09 | $59.59K 10-Q · filed 2012-08-14 | |||||||||
| 2012-03-31 | $4.00K 10-K · filed 2015-06-09 | $3.87K 10-Q · filed 2012-05-15 | $10.40K derived: sum of 2 quarters · filed 2015-06-09 | $11.12K derived: sum of 3 quarters · filed 2015-06-09 | $11.81K derived: sum of 4 quarters · filed 2015-06-09 | $20.82K 10-Q · filed 2012-05-15 | ||||||||
| 2011-12-31 | $6.40K derived: 10-K 12 month − 10-Q 9 month · filed 2014-06-10 | $7.12K derived: sum of 2 quarters · filed 2014-06-10 | $7.81K derived: sum of 3 quarters · filed 2014-06-10 | $9.00K 10-K · filed 2014-06-10 | ||||||||||
| 2011-09-30 | $714.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-14 | $1.41K derived: sum of 2 quarters · filed 2012-11-14 | $2.60K 10-Q · filed 2012-11-14 | |||||||||||
| 2011-06-30 | $695.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $1.88K 10-Q · filed 2012-08-14 | ||||||||||||
| 2011-03-31 | $1.19K 10-Q · filed 2012-05-15 | |||||||||||||
| 2010-12-31 | $4.00K 10-KT · filed 2013-05-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |